General Mills
GIS
$34.29
+2.91%
General Mills is a global packaged-food manufacturer whose portfolio spans cereal (Cheerios), snacks (Nature Valley), convenient meals (Old El Paso), dough and baking products (Pillsbury, Betty Crocker), pet food (Blue Buffalo), and super-premium ice cream (Häagen-Dazs), with roughly 80% of revenue generated in the United States and the remainder spread across Canada, Europe, Australia, Asia, and Latin America. It is a mature, brand-owning staple of the Consumer Defensive sector — a scale incumbent rather than a disruptor, competing on shelf space, brand equity, and distribution against peers like Kraft Heinz, Campbell's, and private-label challengers. The current investor debate centers on whether GIS is a deep-value dividend play or a value trap: the stock has fallen roughly 28% over the past year amid soft volume trends, a 2.8% year-over-year revenue decline in the latest quarter, and cautious fiscal 2027 guidance, even as management executes portfolio pruning (the Brazil exit) and delivered a headline EPS beat. A large non-cash impairment drove a reported Q4 net loss, muddying headline profitability and keeping sentiment defensive despite a dividend yield near 7% that anchors the income-investor case.…
GIS
General Mills
$34.29
Related headlines
Investment Opinion: Should I buy GIS Today?
Rating: Hold. GIS is a deeply discounted, high-yield packaged-food incumbent whose 10.9x forward PE and 7.1% dividend yield offer value only if volumes stabilize; the analyst consensus 'hold' (mean 3.05) and average target of $37.00 (+7.6% upside) anchor a neutral stance. The core thesis is that the market has priced in pessimism — 1.0x sales and 9.37x EV/EBITDA are at multi-year lows — but there is no evidence yet of an inflection.
Supporting evidence is mixed but leans toward value: forward PE of 10.9x versus a sector in the mid-to-high teens implies a 25-35% discount; PS of 1.00x and P/B of 2.50x are at the bottom of the historical 5-10x and 3.9-4.9x ranges; TTM free cash flow of $1.55 billion covers the ~$1.32 billion annual dividend; and the latest quarter was profitable with a 9.04% net margin and 14.43% operating margin. However, revenue growth is -2.83% YoY, gross margin has been range-bound at 30.6-34.8%, and the impairment overhang keeps trailing earnings negative (EPS -$0.005).
Key risks that could invalidate the thesis: (1) a dividend cut if FCF deteriorates below the ~$1.32 billion payout, (2) further volume erosion in pet and ice cream signaling structural brand impairment, and (3) leverage (1.84x D/E, 0.68 current ratio) limiting flexibility. The rating would upgrade to Buy if organic revenue growth turns positive or if the stock holds above $37-$38 with volume confirmation; it would downgrade to Sell if revenue declines accelerate beyond -5% or if the dividend coverage ratio falls below 1.0x. Valuation verdict: undervalued relative to history and peers, but fairly valued given the negative growth trajectory — a classic value trap risk.
Sign up to view all
GIS 12-Month Price Forecast
GIS presents a classic deep-value versus value-trap debate: valuation is at cycle lows (10.9x forward PE, 1.0x sales, 9.37x EV/EBITDA) and the 7.1% dividend yield is well covered by $1.55 billion FCF, but revenue is declining at -2.83% YoY and the $2.94 billion impairment raises questions about brand value. The technical picture is weak (-28.25% over one year, -41.38 relative strength vs. the S&P 500) and analyst sentiment is inert with no upgrades. I would upgrade to bullish if organic revenue growth turns positive or if the stock reclaims $37-$38 with volume confirmation; I would downgrade to bearish if revenue declines accelerate beyond -5% or if dividend coverage falls below 1.0x. With a beta of 0.02, the stock offers diversification but little market-driven upside, making it a holding for income-focused investors rather than growth seekers.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on General Mills's 12-month outlook, with a consensus price target around $37.00 and implied upside of +7.9% versus the current price.
Average Target
$37.00
0 analysts
Implied Upside
+7.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$30 - $45
Analyst target range
Coverage is solid with 18 analysts, but sentiment is decidedly neutral: the consensus recommendation is "hold" with a mean rating of 3.05 (where 1 is strong buy and 5 is strong sell), and the average target price of $37.00 implies roughly +7.6% upside from the current $34.39. That modest upside, combined with a consensus EPS estimate of $3.43 (range $3.35–$3.53) on revenue of $18.31 billion (range $17.97–$18.72 billion), signals that the Street sees stabilization rather than recovery — the consensus is neither bullish nor bearish, but resigned. The target range of $30.00 to $45.00 is wide relative to the average, spanning -12.8% downside to +30.9% upside, which signals genuine disagreement about whether the impairment and volume weakness are transitory or structural. The high target of $45 assumes multiple re-rating toward historical norms, volume stabilization, and successful portfolio pruning; the low target of $30 prices in continued volume erosion, margin compression from input costs, and dividend-coverage concerns. Institutional ratings show a clear pattern of inertia rather than conviction: recent actions are almost entirely reiterations (Barclays Equal Weight, RBC Outperform, TD Cowen Hold, Evercore In Line, BofA Neutral, Wells Fargo Underweight), with no upgrades and a persistent underweight from Wells Fargo — a signal that analysts are waiting for evidence of a turn rather than positioning ahead of one.
Bulls vs Bears: GIS Investment Factors
The bear case currently carries stronger evidence: revenue is contracting at -2.83% YoY, the balance sheet is leveraged at 1.84x D/E with a 0.68 current ratio, and the stock is in a severe downtrend (-28.25% over one year, -41.38 relative strength vs. the S&P 500) with no analyst upgrades. The bull case rests on valuation and income — 10.9x forward PE, 1.0x sales, a 7.1% dividend yield covered by $1.55 billion FCF — which is compelling only if volumes stabilize. The single most important tension is whether the $2.94 billion impairment was a one-time cleanup that clears the deck for a re-rating, or a signal that brand value in pet and ice cream is structurally impaired; how that resolves will determine whether GIS is a deep-value dividend play or a value trap.
Bullish
- Deep value on forward earnings: At $34.39, GIS trades at just 10.9x forward EPS of $3.43 and 1.0x sales, versus a packaged-food sector typically in the mid-to-high teens PE and 11-13x EV/EBITDA. EV/EBITDA of 9.37x and P/B of 2.50x sit at the bottom of the stock's multi-year range (historical PS 5-10x, P/B 3.9-4.9x), implying the market has already priced in significant pessimism.
- 7.1% dividend yield well covered by FCF: The dividend yield of 7.14% is roughly 5x the S&P 500's, and TTM free cash flow of $1.55 billion comfortably covers the ~$1.32 billion annual dividend (quarterly payout $330 million). Quarterly operating cash flow of $298 million and a normalized payout ratio near 0.83 leave room to sustain the payout even through a soft volume cycle.
- Profitability intact ex-impairment: The latest quarter delivered net income of $397 million (9.04% net margin), gross margin of 33.88%, and operating margin of 14.43% — respectable for packaged foods. The prior Q4's $2.01 billion net loss was driven by a $2.94 billion non-cash charge, not operating deterioration, so normalized earnings power remains intact.
- Analyst target implies modest upside: The 18-analyst consensus average target of $37.00 implies +7.6% upside from $34.39, with a high target of $45.00 (+30.9%). While the consensus rating is 'hold' (mean 3.05), the wide $30-$45 range signals disagreement rather than uniform bearishness, and any volume stabilization could trigger re-rating toward the high end.
Bearish
- Revenue contraction is structural: Latest quarter revenue of $4.39 billion fell 2.83% year-over-year, extending softness across the fiscal year (Q4 $4.61B, Q3 $4.44B, Q2 $4.86B). The portfolio is weighted toward mature center-store categories — snacks $1.03B, cereal $756M, pet $651M — facing private-label pressure, suggesting secular decline rather than a cyclical dip.
- Impairment signals brand-value erosion: The $2.94 billion non-cash charge that drove the Q4 net loss of $2.01 billion (EPS -$3.74) raises the question of whether pet (Blue Buffalo) and super-premium ice cream (Häagen-Dazs) brands are impaired. Trailing EPS of -$0.005 and trailing PE of -210x make headline profitability meaningless, and ROE of -1.19% reflects the damage.
- Leverage and thin liquidity: Debt-to-equity of 1.84x, a current ratio of just 0.68 (well below 1.0), and interest coverage of roughly 4.5x (interest expense $142.2M vs. operating income $633.6M) leave little cushion for a defensive staple. Returns are leverage-assisted (equity multiplier 4.06x) rather than operationally superior, with normalized ROE in the 5-7% range.
- Severe technical downtrend: GIS is down 28.25% over one year and 24.78% YTD, with a relative strength of -41.38 points versus the S&P 500 and a max drawdown of -38.04%. At $34.39 the stock sits at only 17.5% of its 52-week range ($31.18-$49.59), just 10.3% above the low, and the latest session's -2.25% drop on 6.19 million shares suggests distribution.
GIS Technical Analysis
GIS is locked in a sustained, multi-quarter downtrend: the stock is down 28.25% over the past year and 24.78% year-to-date, a stark underperformance versus the S&P 500's +13.13% one-year return (relative strength of -41.38 points). At $34.39, the shares sit at roughly 17.5% of the 52-week range of $31.18–$49.59 — near the bottom of the band, which historically signals either a capitulation value opportunity or a falling knife, and the -38.04% max drawdown confirms the severity of the de-rating. The stock is trading only about 10.3% above its 52-week low, meaning the margin of safety from a technical standpoint is thin and the burden of proof sits with the bulls. Recent momentum remains negative but is decelerating in severity: the 1-month change of -3.99% and 3-month change of -4.55% are both modestly worse than the 6-month change of -1.66%, indicating the downtrend has reasserted itself after a summer rally that peaked near $41.55 in late August. That summer advance (from roughly $32 in early July to $41.55) has fully unwound, and the sharp -2.25% single-day drop on the latest session (from $35.18 to $34.39) on elevated volume of 6.19 million shares suggests distribution rather than accumulation; the 1-month relative strength of -2.97 points versus SPY confirms GIS is lagging even a soft tape. Key support sits at the 52-week low of $31.18, with the October consolidation zone around $31.67–$32.18 as the first line of defense; resistance is the August high near $41.55 and, above that, the 52-week high of $49.59. A decisive break below $31.18 would likely trigger momentum-driven selling and open a new leg lower, while reclaiming $37–$38 would be the first evidence of a trend reversal. Notably, the reported beta of 0.02 implies essentially zero correlation to the market — an artifact of the stock's idiosyncratic, defensive behavior — so traditional market-beta position sizing is of limited use here; risk is company-specific (guidance, volumes, dividend coverage) rather than market-driven.
Beta
0.02
0.02x market volatility
Max Drawdown
-37.8%
Largest decline past year
52-Week Range
$31-$50
Price range past year
Annual Return
-27.1%
Cumulative gain past year
| Period | GIS Return | S&P 500 |
|---|---|---|
| 1m | +6.6% | -0.9% |
| 3m | -4.1% | +1.2% |
| 6m | -1.2% | +4.9% |
| 1y | -27.1% | +11.2% |
| ytd | -25.0% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GIS Fundamental Analysis
Revenue is contracting: the most recent quarter (ended 2026-08-30) posted $4.39 billion, down 2.83% year-over-year, extending a pattern of softness across the fiscal year (Q4 2026 revenue of $4.61 billion, Q3 of $4.44 billion, Q2 of $4.86 billion). Segment data shows snacks as the largest contributor at $1.03 billion, followed by cereal at $756 million, pet at $651 million, convenient meals at $647 million, dough at $516 million, baking mixes at $469 million, and super-premium ice cream at just $232 million — a portfolio heavily weighted toward mature, low-growth center-store categories facing private-label pressure. The trajectory implies a business in modest secular decline rather than cyclical dip, which is the core bear argument; the Brazil divestiture and portfolio pruning are attempts to stabilize the mix, but organic growth remains elusive. Profitability is bifurcated: the latest quarter was solidly profitable with net income of $397 million (9.04% net margin), gross margin of 33.88%, and operating margin of 14.43%, but the prior Q4 included a massive $2.01 billion net loss driven by a $2.94 billion non-cash charge, which is why trailing EPS is -$0.005 and trailing PE is meaningless at -210x. Gross margin has been range-bound between 30.6% and 34.8% over recent quarters, showing no structural expansion, while the operating margin of 14.43% is respectable for packaged foods but below the company's own historical mid-teens-plus levels. The key question is whether the impairment was a one-time cleanup that clears the deck or a signal of impaired brand value in pet and ice cream. The balance sheet carries meaningful leverage: debt-to-equity of 1.84x, a current ratio of just 0.68 (well below 1.0, indicating thin liquidity), and interest coverage of roughly 4.5x — adequate but not comfortable for a defensive staple. Positively, TTM free cash flow of $1.55 billion and quarterly operating cash flow of $298 million comfortably fund the $330 million quarterly dividend, though the payout ratio of -15.0 (distorted by the impairment) and the historical 0.83 payout ratio on normalized earnings leave limited cushion. ROE of -1.19% and ROA of 5.65% reflect the impairment drag; normalized ROE in the 5–7% range is low for the sector and reflects a 4.06x equity multiplier — returns are leverage-assisted rather than operationally superior.
Quarterly Revenue
$4.4B
2026-08
Revenue YoY Growth
-2.8%
YoY Comparison
Gross Margin
33.9%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GIS Overvalued?
Because trailing net income is negative (EPS of -$0.005, trailing PE of -210x), the PE ratio is not a valid primary metric; I therefore lead with the forward PE of 10.9x on consensus FY EPS of $3.43, cross-checked against EV/EBITDA of 9.37x and EV/Sales of 1.73x. The gap between the meaningless trailing multiple and the 10.9x forward figure reflects the market's expectation that the impairment was non-recurring and that earnings normalize — but even on that normalized basis, 10.9x is a low absolute multiple that prices in little growth. The PS ratio of 1.00x and P/B of 2.50x are the cleanest cross-checks: a 1.0x sales multiple for a branded food company with 34% gross margins is historically cheap. Against packaged-food peers, GIS screens at a discount: a forward PE near 11x versus a sector typically trading in the mid-to-high teens implies a roughly 25–35% discount, and EV/EBITDA of 9.4x is below the 11–13x range common for large-cap staples. That discount is partly justified by negative organic growth (-2.8% YoY), leverage at 1.84x D/E, and the impairment overhang, but it arguably over-penalizes a business still generating $1.55 billion in FCF and a 7.1% dividend yield. Historically, GIS traded at PS ratios of 5–10x (2022–2024) and P/B of 3.9–4.9x; today's PS of 1.00x and P/B of 2.50x are at the very bottom of the multi-year band, with the historical PE range of roughly 11–26x (excluding impairment-distorted periods) framing the current forward 10.9x as a cycle-low valuation. The market is pricing in pessimism — either a genuine value opportunity if volumes stabilize, or warranted caution if the decline is structural.
PE
-210.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated for a defensive staple. Revenue fell 2.83% YoY to $4.39 billion in the latest quarter, and the portfolio's heavy weighting toward mature center-store categories (snacks $1.03B, cereal $756M) exposes it to private-label share gains. The balance sheet carries debt-to-equity of 1.84x, a current ratio of just 0.68, and interest coverage of roughly 4.5x (interest expense $142.2M against operating income $633.6M), leaving limited cushion. The $2.94 billion non-cash impairment that produced a $2.01 billion Q4 net loss raises the risk that Blue Buffalo pet and Häagen-Dazs ice cream brands are overvalued on the balance sheet, and the -15.0 payout ratio (distorted by the impairment) versus a normalized 0.83 ratio leaves little room for a dividend cut without a sharp price reaction.
Market and competitive risks center on valuation compression and relative underperformance. GIS trades at 10.9x forward PE and 1.0x sales — already a discount to the mid-to-high-teens sector multiple — but the discount is justified by negative organic growth and could widen if volumes deteriorate further. The stock's beta of 0.02 means it offers little market correlation, so risk is idiosyncratic: guidance, volumes, and dividend coverage rather than macro beta. Competitive pressure from private label and peers like Kraft Heinz and Campbell's, plus input-cost inflation (fertilizer and fuel costs are rising per recent news), threatens margins that are already range-bound between 30.6% and 34.8% gross. Analyst sentiment is inert — 18 analysts at a 'hold' consensus (3.05) with a persistent Wells Fargo Underweight and no upgrades — meaning any negative surprise could trigger downgrades.
Worst-case scenario: a renewed volume decline combines with margin compression from input costs and a dividend-coverage scare, driving the stock below its 52-week low of $31.18. From the current $34.39, that represents a decline of about -9.3%; a move to the analyst low target of $30.00 implies -12.8%. A more severe de-rating toward the historical low end of the valuation band (e.g., PS below 0.9x) could push shares toward the mid-$20s, a loss of roughly -25% to -30% from current levels. The -38.04% max drawdown shows how far the stock can fall in a sustained bear phase, and with the stock only 10.3% above its 52-week low, the technical margin of safety is thin.
FAQ
The most severe risk is a dividend cut: the 7.1% yield is covered by $1.55 billion FCF against a ~$1.32 billion payout, but a further volume decline or margin compression could strain coverage and trigger a sharp sell-off. Second is structural revenue decline — the -2.83% YoY contraction in mature center-store categories (snacks $1.03B, cereal $756M) could accelerate as private label gains share. Third is balance-sheet leverage: debt-to-equity of 1.84x and a current ratio of 0.68 leave limited flexibility, and interest coverage of roughly 4.5x is adequate but not comfortable. Fourth is impairment risk — the $2.94 billion charge raises the possibility that Blue Buffalo or Häagen-Dazs brand values are overstated and could require further write-downs.
The 12-month forecast has three scenarios: a base case (50% probability) of $35-$39, assuming revenue declines moderate to -1% to -2% and the dividend is maintained, aligning with the analyst average target of $37.00; a bull case (25% probability) of $42-$45, assuming volume stabilization and a re-rating toward historical multiples, aligning with the analyst high target of $45.00; and a bear case (25% probability) of $28-$31, assuming accelerating volume declines or a dividend scare, aligning with the analyst low target of $30.00 and the 52-week low of $31.18. The base case is most likely, with the key assumption being that the impairment was non-recurring and that organic growth stabilizes near flat.
GIS appears undervalued on most metrics: forward PE of 10.9x versus a packaged-food sector in the mid-to-high teens, PS of 1.00x versus a historical 5-10x range, P/B of 2.50x versus a historical 3.9-4.9x range, and EV/EBITDA of 9.37x versus the 11-13x sector norm. The trailing PE of -210x is meaningless due to the $2.94 billion impairment, so forward metrics are the relevant guide. The market is pricing in pessimism — little to no growth and potential dividend risk — which implies that any stabilization in volumes could drive a re-rating toward the $37-$45 range. However, the discount is partly justified by negative organic growth and leverage, so the stock is fairly valued given its trajectory rather than deeply undervalued.
From a risk/reward perspective, GIS offers a modest +7.6% upside to the analyst average target of $37.00 against a downside of roughly -9.3% to the 52-week low of $31.18, a roughly 0.8:1 reward-to-risk ratio that is not compelling on its own. The 7.1% dividend yield provides a substantial income cushion and is covered by $1.55 billion in TTM free cash flow, which supports the bull case for income investors. However, revenue is declining at -2.83% YoY, the balance sheet is leveraged at 1.84x debt-to-equity with a 0.68 current ratio, and the stock is in a severe downtrend with no analyst upgrades. It is a good buy primarily for patient income investors with a long horizon who can tolerate further downside toward $31, and only if they believe volumes will stabilize; it is not a good buy for growth-oriented or short-term investors.
GIS is better suited for long-term income-focused investment than short-term trading. The stock's beta of 0.02 means it has essentially no market correlation, so short-term trading lacks the volatility-driven opportunities of higher-beta names, while the 7.1% dividend yield rewards patience. The severe downtrend (-28.25% over one year, -41.38 relative strength vs. the S&P 500) and thin technical margin of safety (only 10.3% above the 52-week low) make short-term entry risky. A minimum holding period of 2-3 years is appropriate to allow for volume stabilization and potential multiple re-rating, with investors monitoring dividend coverage and organic growth each quarter.